9 completed, 1 terminated, 1 unknown. 11 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 11 | Completed 9, Terminated 1, Unknown 1 |
Follow ferric gluconate: new trials by email Literature Review of ferric gluconate trials Research Report on ferric gluconate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IV Sodium Ferric Gluconate Complex in Patients Undergoing TAVI IV Sodium Ferric Gluconate Complex - Iron Deficiency Anemia Due to Blood Loss, Aortic Stenosis | Phase 4 | Unknown | Rambam Health Care Campus | 200 | 2020-10-18 | 2022-10-27 |
| IV Iron in Acute Decompensated Heart Failure IV iron - Sodium Ferric Gluconate Complex - Heart Failure | Phase 4 | Completed | Rambam Health Care Campus | 34 | 2019-09-01 | 2023-04-11 |
| Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure Sodium ferric gluconate - Heart Failure, Iron Deficiency Anemia | Phase 4 | Completed | University of North Carolina, Chapel Hill | 13 | 2011-04-01 | 2015-08-25 |
| Effect of Two Iron Preparations on Protein in the Urine Sodium Ferric Gluconate and Iron sucrose - Kidney Failure, Chronic, Anemia, Iron-Deficiency | Phase 4 | Completed | Watson Pharmaceuticals | 12 | 2006-06-01 | 2012-08-14 |
| DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin) Sodium ferric gluconate, - Anemia, Iron-Deficiency, Kidney Failure, Chronic | Phase 4 | Completed | Watson Pharmaceuticals | 134 | 2004-09-01 | 2015-12-10 |
| Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients. Oral Iron, sodium ferric gluconate - Anemia | Phase 4 | Terminated | Sanofi | 112 | 2003-12-30 | 2021-06-24 |
| Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients Ferrlecit (sodium ferric gluconate complex in sucrose injection) - Anemia | Phase 4 | Completed | Watson Pharmaceuticals | 59 | 2003-06-01 | 2012-08-14 |
| Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Sodium Ferric Gluconate Complex in Sucrose Injection, Ferrous sulfate tablets - Anemia, Iron-Deficiency, Kidney Failure, Chronic | Phase 4 | Completed | Watson Pharmaceuticals | 89 | 2003-04-01 | 2012-03-29 |
| Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients Sodium Ferric Gluconate Complex in Sucrose. - Anemia | Phase 4 | Completed | Watson Pharmaceuticals | 23 | 2003-04-01 | 2009-09-28 |
| Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents Sodium Ferric Gluconate complex in sucrose, Ferrous sulfate tablets - Anemia, Iron-Deficiency, Kidney Failure, Chronic | Phase 4 | Completed | Watson Pharmaceuticals | 52 | 2003-04-01 | 2012-03-29 |
| Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy Sodium ferric gluconate, ferrous sulfate, standard of care - Anemia | Phase 4 | Completed | Watson Pharmaceuticals | 180 | 2002-05-01 | 2012-03-02 |
Anemia (6) · Anemia, Iron-Deficiency (5) · Iron Deficiencies (4) · Kidney Failure, Chronic (4) · Bronchiolitis Obliterans Syndrome (2) · Heart Failure (2) · Renal Insufficiency (2) · Renal Insufficiency, Chronic (2) · Aortic Valve Stenosis (1)
Watson Pharmaceuticals (7) · Rambam Health Care Campus (2) · Sanofi (1) · University of North Carolina, Chapel Hill (1)
United States (9) · Israel (2) · Puerto Rico (2) · Mexico (1) · Poland (1) · Russia (1) · Serbia (1)
Adel R. Rizkala, Pharm.D., MS (2) · Erez Marcusohn, MD (2) · Gary Hoel, RPh, PhD (2) · Adel R Rizkala, PharmD, MS (1) · Jo Ellen Rodgers, PharmD (1) · Naomi Dahl, Pharm.D. (1) · Naomi V. Dahl, Pharm.D. (1)
PMID 16520948, PMID 17035697, PMID 17267740, PMID 17296819, PMID 17396118, PMID 17622274, PMID 18216316, PMID 19034302, PMID 35503997, PMID 41870899